Time to next isolation of PA · children (aged 1 to 12 years) with CF and a newly isolated PA infection
Summary of findings: cycled probably leads to higher time to next isolation of PA compared with culture‐based antibiotic therapy (moderate certainty).
1 finding from 1 review
Quality of life · children (aged 1 to 12 years) with CF and a newly isolated PA infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Lung function: FEV1 mL (change from baseline) · children (aged 1 to 12 years) with CF and a newly isolated PA infection
1 finding from 1 review
Pulmonary exacerbations · children (aged 1 to 12 years) with CF and a newly isolated PA infection
1 finding from 1 review
Time to chronic PA · children (aged 1 to 12 years) with CF and a newly isolated PA infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: severe adverse events (total) · children (aged 1 to 12 years) with CF and a newly isolated PA infection
Summary of findings: cycled showed no clear difference in adverse events: severe adverse events (total) compared with culture‐based antibiotic therapy (moderate certainty).
1 finding from 1 review
Emergence of novel bacteria: isolation of novel gram negative organisms · children (aged 1 to 12 years) with CF and a newly isolated PA infection
Summary of findings: cycled showed no clear difference in emergence of novel bacteria: isolation of novel gram negative… compared with culture‐based antibiotic therapy (moderate certainty).
1 finding from 1 review
HbA1c (%) · adults with CFRD
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · adults with CFRD
Summary of findings: insulin showed no clear difference in FEV1 % predicted: change from baseline compared with placebo (low certainty).
1 finding from 1 review
FVC (% predicted) Change from baseline · adults with CFRD
Summary of findings: insulin showed no clear difference in FVC % predicted: change from baseline compared with placebo (low certainty).
1 finding from 1 review
Change in BMI · adults with CFRD
Summary of findings: insulin showed no clear difference in BMI(kg/m²): change from baseline compared with placebo (low certainty).
1 finding from 1 review
Hypoglycemia: number of episodes · adults with CFRD
Summary of findings: insulin showed no clear difference in hypoglycemia: number of episodes compared with placebo (low certainty).
1 finding from 1 review
Death (all causes) · people with CKD
It is very uncertain whether summary of findings: Calcium changes death (all causes) compared with placebo/usual care (very low certainty).
1 finding from 1 review
Cardiovascular mortality · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypercalcaemia · people with CKD
Summary of findings: Calcium may leads to higher hypercalcaemia compared with placebo/usual care (low certainty).
1 finding from 1 review
Nausea · people with CKD
Summary of findings: Calcium showed no clear difference in nausea compared with placebo/usual care (low certainty).
1 finding from 1 review
Vomiting · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Constipation · people with CKD
It is very uncertain whether summary of findings: Calcium changes constipation compared with placebo/usual care (very low certainty).
1 finding from 1 review
Serum phosphate level · people with CKD
1 finding from 1 review
Coronary artery calcification score · people with CKD
1 finding from 1 review